A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 235.28
GOOG 1.253.07
MSFT 139.69
BAC 30.26
FB 190.39

Recently Added

RLLCF 0.01
FLES 0.00
BGS 16.40
APLE 16.21
OXLC 9.76

Gaining Speed

APLE 16.21
RLLCF 0.01
FLES 0.00
BGS 16.40
CVS 66.50

Oppenheimer Starts Fate Therapeutics (FATE) at Outperform

Oppenheimer initiates coverage on Fate Therapeutics (NASDAQ: FATE) with a Outperform rating and a price target of $27.00.For an analyst ratings summary and ratings history on Fate Therapeutics click here. For more ratings news on Fate Therapeutics click here.Shares of Fate Therapeutics closed at $20.50 yesterday.

Read More




Get Alerted When News Hits On This Stock - FREE!